GLP-1 drugs linked to taste disturbances and dry mouth in 364k adverse reports

Analysis of over 364,000 adverse event reports for GLP-1 weight-loss and diabetes drugs reveals a notable subset involving oral symptoms like taste changes and dry mouth. The finding is based on self-reported data, so causality and prevalence remain uncertain. This adds to the known side-effect profile of a widely used drug class, with potential implications for patient adherence and regulatory scrutiny.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works